Eitan Keizman, David Mishaly, Eilon Ram, Soslan Urtaev, Shai Tejman-Yarden, Tal Tirosh Wagner, Alain E Serraf
{"title":"常温与低温诺伍德手术。","authors":"Eitan Keizman, David Mishaly, Eilon Ram, Soslan Urtaev, Shai Tejman-Yarden, Tal Tirosh Wagner, Alain E Serraf","doi":"10.1177/21501351221140330","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Either deep hypothermia with circulatory arrest or hypothermic perfusion with antegrade selective cerebral perfusion is used during the Norwood procedure for hypoplastic left heart syndrome. Normothermic perfusion has been described for pediatric patients. The aim of this study was to compare the early outcomes of patients undergoing the Norwood procedure with antegrade selective cerebral perfusion under hypothermia with the procedure under normothermia.</p><p><strong>Methods: </strong>From 2005 to 2020, 117 consecutive patients with hypoplastic left heart syndrome underwent the Norwood procedure: 68 (58.2%) under hypothermia and 49 (41.8%) under normothermia. Antegrade selective cerebral perfusion flow was adjusted to maintain right radial arterial pressure above 50 mm Hg, and a flow rate of 40 to 50 mL kg<sup>-1</sup> min<sup>-1</sup>. Baseline characteristics, operative data, and postoperative outcomes including lactate recovery time were compared.</p><p><strong>Results: </strong>The baseline characteristics and cardiovascular diagnosis were similar in both groups. The normothermic group had a significantly shorter bypass time (in minutes) of 90.31 (±31.60) versus 123.63 (±25.33), a cross-clamp time of 45.24 (±16.35) versus 81.93 (±16.34), and an antegrade selective cerebral perfusion time of 25.61 (±13.84) versus 47.30 (±14.35) (<i>P</i> < .001). There were no statistically significant differences in the immediate postoperative course, or in terms of in-hospital mortality, which totaled 9 (18.4%) in the normothermic group, and 10 (14.9%) in the hypothermic group (<i>P</i> = .81).</p><p><strong>Conclusion: </strong>The normothermic Norwood procedure with selective cerebral perfusion is feasible and safe in terms of in-hospital mortality and short-term outcomes. It is comparable to the standard hypothermic Norwood with selective cerebral perfusion.</p>","PeriodicalId":23974,"journal":{"name":"World Journal for Pediatric and Congenital Heart Surgery","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Normothermic Versus Hypothermic Norwood Procedure.\",\"authors\":\"Eitan Keizman, David Mishaly, Eilon Ram, Soslan Urtaev, Shai Tejman-Yarden, Tal Tirosh Wagner, Alain E Serraf\",\"doi\":\"10.1177/21501351221140330\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Either deep hypothermia with circulatory arrest or hypothermic perfusion with antegrade selective cerebral perfusion is used during the Norwood procedure for hypoplastic left heart syndrome. Normothermic perfusion has been described for pediatric patients. The aim of this study was to compare the early outcomes of patients undergoing the Norwood procedure with antegrade selective cerebral perfusion under hypothermia with the procedure under normothermia.</p><p><strong>Methods: </strong>From 2005 to 2020, 117 consecutive patients with hypoplastic left heart syndrome underwent the Norwood procedure: 68 (58.2%) under hypothermia and 49 (41.8%) under normothermia. Antegrade selective cerebral perfusion flow was adjusted to maintain right radial arterial pressure above 50 mm Hg, and a flow rate of 40 to 50 mL kg<sup>-1</sup> min<sup>-1</sup>. Baseline characteristics, operative data, and postoperative outcomes including lactate recovery time were compared.</p><p><strong>Results: </strong>The baseline characteristics and cardiovascular diagnosis were similar in both groups. The normothermic group had a significantly shorter bypass time (in minutes) of 90.31 (±31.60) versus 123.63 (±25.33), a cross-clamp time of 45.24 (±16.35) versus 81.93 (±16.34), and an antegrade selective cerebral perfusion time of 25.61 (±13.84) versus 47.30 (±14.35) (<i>P</i> < .001). There were no statistically significant differences in the immediate postoperative course, or in terms of in-hospital mortality, which totaled 9 (18.4%) in the normothermic group, and 10 (14.9%) in the hypothermic group (<i>P</i> = .81).</p><p><strong>Conclusion: </strong>The normothermic Norwood procedure with selective cerebral perfusion is feasible and safe in terms of in-hospital mortality and short-term outcomes. It is comparable to the standard hypothermic Norwood with selective cerebral perfusion.</p>\",\"PeriodicalId\":23974,\"journal\":{\"name\":\"World Journal for Pediatric and Congenital Heart Surgery\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2023-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal for Pediatric and Congenital Heart Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/21501351221140330\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal for Pediatric and Congenital Heart Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/21501351221140330","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 1
摘要
背景:在诺伍德手术治疗左心发育不全综合征时,要么采用深度低温伴循环停止,要么采用低温灌注伴顺行选择性脑灌注。正常灌注已被描述用于儿科患者。本研究的目的是比较接受诺伍德手术的患者在低温下顺行选择性脑灌注与常温下手术的早期结果。方法:2005 - 2020年,117例左心发育不全综合征患者连续行诺伍德手术,其中低温68例(58.2%),常温49例(41.8%)。调整顺行选择性脑灌注流量,使右桡动脉压维持在50 mm Hg以上,血流速率维持在40 ~ 50 mL kg-1 min-1。比较基线特征、手术数据和术后结果,包括乳酸恢复时间。结果:两组患者的基线特征和心血管诊断相似。常温组旁路时间(分钟)为90.31(±31.60)比123.63(±25.33),交叉夹持时间为45.24(±16.35)比81.93(±16.34),顺行选择性脑灌注时间为25.61(±13.84)比47.30(±14.35)(P < 0.001)。两组术后即时病程及住院死亡率均无统计学差异,常温组为9例(18.4%),低温组为10例(14.9%)(P = 0.81)。结论:从住院死亡率和短期预后来看,常温诺伍德手术加选择性脑灌注是可行和安全的。它与标准的低低温诺伍德选择性脑灌注相当。
Normothermic Versus Hypothermic Norwood Procedure.
Background: Either deep hypothermia with circulatory arrest or hypothermic perfusion with antegrade selective cerebral perfusion is used during the Norwood procedure for hypoplastic left heart syndrome. Normothermic perfusion has been described for pediatric patients. The aim of this study was to compare the early outcomes of patients undergoing the Norwood procedure with antegrade selective cerebral perfusion under hypothermia with the procedure under normothermia.
Methods: From 2005 to 2020, 117 consecutive patients with hypoplastic left heart syndrome underwent the Norwood procedure: 68 (58.2%) under hypothermia and 49 (41.8%) under normothermia. Antegrade selective cerebral perfusion flow was adjusted to maintain right radial arterial pressure above 50 mm Hg, and a flow rate of 40 to 50 mL kg-1 min-1. Baseline characteristics, operative data, and postoperative outcomes including lactate recovery time were compared.
Results: The baseline characteristics and cardiovascular diagnosis were similar in both groups. The normothermic group had a significantly shorter bypass time (in minutes) of 90.31 (±31.60) versus 123.63 (±25.33), a cross-clamp time of 45.24 (±16.35) versus 81.93 (±16.34), and an antegrade selective cerebral perfusion time of 25.61 (±13.84) versus 47.30 (±14.35) (P < .001). There were no statistically significant differences in the immediate postoperative course, or in terms of in-hospital mortality, which totaled 9 (18.4%) in the normothermic group, and 10 (14.9%) in the hypothermic group (P = .81).
Conclusion: The normothermic Norwood procedure with selective cerebral perfusion is feasible and safe in terms of in-hospital mortality and short-term outcomes. It is comparable to the standard hypothermic Norwood with selective cerebral perfusion.